Capital Fund Management (CFM)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97M | Buy |
+20,591
| New | +$4.97M | 0.01% | 389 |
|
|
2024
Q2 | – | Sell |
-11,188
| Closed | -$3.87M | – | 676 |
|
|
2024
Q1 | $3.87M | Buy |
+11,188
| New | +$3.87M | 0.01% | 367 |
|
|
2021
Q1 | – | Sell |
-24,407
| Closed | -$14.2M | – | 567 |
|
|
2020
Q4 | $14.2M | Buy |
+24,407
| New | +$14.2M | 0.13% | 52 |
|
|
2019
Q4 | – | Sell |
-1,561
| Closed | -$519K | – | 900 |
|
|
2019
Q3 | $519K | Buy |
+1,561
| New | +$519K | ﹤0.01% | 544 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 730 |
|
|
2018
Q4 | – | Sell |
-5,200
| Closed | -$1.63M | – | 836 |
|
|
2018
Q3 | $1.63M | Buy |
+5,200
| New | +$1.63M | 0.01% | 508 |
|
|
2014
Q3 | – | Sell |
-3,100
| Closed | -$371K | – | 644 |
|
|
2014
Q2 | $371K | Buy |
+3,100
| New | +$371K | ﹤0.01% | 598 |
|